New Delhi: A Subject Expert Committee (SEC) of central government today (Monday) gave its nod for the emergency use authorization of the Russia’s COVID-19 vaccine SPUTNIK V, sources said. The Sputnik V will be the third vaccine approved by India after SII’s Covishield and Bharat Biotech’s Covaxin.
As per Russia, Sputnik V is the world’s first registered COVID vaccine based on a well-studied human adenoviral vector-based platform and is already registered in more than 55 countries. With the announcement of the emergency use, Dr. Reddy’s Laboratories, the manufacturer of the Sputnik V vaccine in India, saw their share value jump over 7 per cent, Russian news agency reported.
